Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: alpha 1 (VI) chain (61 AA); Collagen alpha-1(VI) chain; Collagen alpha-2(VI) chain; collagen VI, alpha-1 polypeptide; collagen VI, alpha-2 polypeptide; collagen, type VI, alpha 1; collagen, type VI, alpha 2; ETS related protein-neurotrophic receptor tyrosine kinase fusion protein; ETV6-NTRK3 fusion; GP145-TrkC; human mRNA for collagen VI alpha-2 C-terminal globular domain; neural receptor protein-tyrosine kinase (trkC); Neurotrophic tyrosine kinase receptor type 3; neurotrophic tyrosine kinase, receptor, type 3; neurotrophin-3; NT-3 growth factor receptor; procollagen, type VI, alpha 1; procollagen, type VI, alpha 2; Trk-C; TrkC tyrosine kinase; tyrosine kinase receptor C
Gene Aliases: AI747156; AW125844; BTHLM1; Col6a-1; Col6a-2; COL6A1; COL6A2; gp145(trkC); GP145-TrkC; NTRK3; Ntrk3_tv3; OPLL; PP3610; RGD1565398; TRKC; UCHMD1; UCMD1